FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald White

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Lymphocytes, Tumor-Infiltrating

Co-author Network

Publications

TOP 3
Peter A Prieto; STEVEN ROSENBERG; Richard M Sherry; Donald E White; James C Yang; Marybeth S Hughes; Udai S Kammula; Catherine L Levy; Giao Q Phan
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.
Melissa M Alvarez-Downing; Mark E Dudley; Suzanne M Inchauste; STEVEN ROSENBERG; Donald E White; John R Wunderlich; Udai S Kammula
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.
STEVEN ROSENBERG; Richard M Sherry; Seth M Steinberg; Donald E White; John R Wunderlich; James C Yang; Marybeth S Hughes; Udai S Kammula; Carolyn M Laurencot; Kathleen E Morton; Giao Q Phan; Nicholas P Restifo; Paul F Robbins; Deborah Citrin; Mark E Dudley
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peter A Prieto; STEVEN ROSENBERG; Richard M Sherry; Donald E White; James C Yang; Marybeth S Hughes; Udai S Kammula; Catherine L Levy; Giao Q Phan
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(7):2039-47.
2012: Melissa M Alvarez-Downing; Mark E Dudley; Suzanne M Inchauste; STEVEN ROSENBERG; Donald E White; John R Wunderlich; Udai S Kammula
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.
World journal of surgical oncology 2012;10():113.
2011: STEVEN ROSENBERG; Richard M Sherry; Seth M Steinberg; Donald E White; John R Wunderlich; James C Yang; Marybeth S Hughes; Udai S Kammula; Carolyn M Laurencot; Kathleen E Morton; Giao Q Phan; Nicholas P Restifo; Paul F Robbins; Deborah Citrin; Mark E Dudley
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4550-7.
2010: Mark E Dudley; Colin A Gross; Michelle M Langhan; Marcos R Garcia; Richard M Sherry; James C Yang; Giao Q Phan; Udai S Kammula; Marybeth S Hughes; Deborah Citrin; Nicholas P Restifo; John R Wunderlich; Peter A Prieto; Jenny J Hong; Russell C Langan; Daniel A Zlott; Kathleen E Morton; Donald E White; Carolyn M Laurencot; STEVEN ROSENBERG
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):6122-31.
2010: Jacob A Klapper; Jeremy L Davis; R Taylor Ripley; Franz O Smith; Dao Nguyen; King F Kwong; Leandro Mercedes; Clinton D Kemp; Aarti Mathur; Donald E White; Mark E Dudley; John R Wunderlich; STEVEN ROSENBERG; David S Schrump
Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience.
The Journal of thoracic and cardiovascular surgery 2010;140(6):1276-82.
2010: R Taylor Ripley; Jeremy L Davis; Jacob A Klapper; Aarti Mathur; Udai S Kammula; Richard E Royal; James C Yang; Richard M Sherry; Marybeth S Hughes; Steven Libutti; Donald E White; Seth M Steinberg; Mark E Dudley; STEVEN ROSENBERG; Itzhak Avital
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.
Annals of surgical oncology 2010;17(1):163-70.
2009: Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; STEVEN ROSENBERG
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Blood 2009;114(8):1537-44.
2008: Mark E Dudley; James C Yang; Richard M Sherry; Marybeth S Hughes; Richard E Royal; Udai S Kammula; Paul F Robbins; JianPing Huang; Deborah Citrin; Susan F Leitman; John R Wunderlich; Nicholas P Restifo; Armen Thomasian; Stephanie G Downey; Franz O Smith; Jacob Klapper; Kathleen E Morton; Carolyn Laurencot; Donald E White; STEVEN ROSENBERG
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5233-9.
2008: Franz O Smith; Stephanie G Downey; Jacob A Klapper; James C Yang; Richard M Sherry; Richard E Royal; Udai S Kammula; Marybeth S Hughes; Nicholas P Restifo; Catherine L Levy; Donald E White; Seth M Steinberg; STEVEN ROSENBERG
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5610-8.
2007: Stephanie G Downey; Jacob A Klapper; Franz O Smith; James C Yang; Richard M Sherry; Richard E Royal; Udai S Kammula; Marybeth S Hughes; Tamika E Allen; Catherine L Levy; Michael Yellin; Geoffrey Nichol; Donald E White; Seth M Steinberg; STEVEN ROSENBERG
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6681-8.
2007: James C Yang; Marybeth Hughes; Udai S Kammula; Richard E Royal; Richard M Sherry; Suzanne Topalian; Kimberly B Suri; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Israel Lowy; Donald E White; STEVEN ROSENBERG
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(8):825-30.
2007: Daniel J Powell; Aloisio Felipe-Silva; Maria J Merino; Mojgan Ahmadzadeh; Tamika Allen; Catherine Levy; Donald E White; Sharon A Mavroukakis; Robert J Kreitman; STEVEN ROSENBERG; Ira Pastan
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(7):4919-28.
2006: Michael H Kershaw; Jennifer A Westwood; Linda L Parker; Gang Wang; Zelig Eshhar; Sharon A Mavroukakis; Donald E White; John R Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C Chen; James C Yang; STEVEN ROSENBERG; Patrick Hwu
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6106-15.
2006: Kimberly R Lindsey; Linda Gritz; Richard M Sherry; Andrea Abati; Patricia A Fetsch; Lisa C Goldfeder; Monica I Gonzales; Kimberly A Zinnack; Linda Rogers-Freezer; Leah R Haworth; Sharon A Mavroukakis; Donald E White; Seth M Steinberg; Nicholas P Restifo; Dennis Panicali; STEVEN ROSENBERG; Suzanne Topalian
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2526-37.
2006: STEVEN ROSENBERG; Richard M Sherry; Kathleen E Morton; James C Yang; Suzanne Topalian; Richard E Royal; Udai S Kammula; Nicholas P Restifo; Marybeth S Hughes; Susan L Schwarz; Lien T Ngo; Sharon A Mavroukakis; Donald E White
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):224-31.
2005: STEVEN ROSENBERG; Richard M Sherry; Kathleen E Morton; William J Scharfman; James C Yang; Suzanne Topalian; Richard E Royal; Udai S Kammula; Nicholas P Restifo; Marybeth S Hughes; Douglas J Schwartzentruber; berman david; Susan L Schwarz; Lien T Ngo; Sharon A Mavroukakis; Donald E White; Seth M Steinberg
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):6169-76.
2005: Mark E Dudley; John R Wunderlich; James C Yang; Richard M Sherry; Suzanne Topalian; Nicholas P Restifo; Richard E Royal; Udai S Kammula; Donald E White; Sharon A Mavroukakis; Linda J Rogers; Gerald J Gracia; Stephanie A Jones; David P Mangiameli; Michelle M Pelletier; Juan Gea-Banacloche; Michael R Robinson; berman david; Armando C Filie; Andrea Abati; STEVEN ROSENBERG
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2346-57.
2004: Hung T Khong; James C Yang; Suzanne Topalian; Richard M Sherry; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(6):472-7.
2004: Steven E Finkelstein; Jorge Carrasquillo; John M Hoffman; Barbara Galen; Peter Choyke; Donald E White; STEVEN ROSENBERG; Richard M Sherry
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.
Annals of surgical oncology 2004;11(8):731-8.
2004: Dina M Elaraj; Donald E White; Seth M Steinberg; Leah R Haworth; STEVEN ROSENBERG; James C Yang
A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(4):259-64.
2003: James C Yang; Richard M Sherry; Seth M Steinberg; Suzanne Topalian; Douglas J Schwartzentruber; Patrick Hwu; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Donald E White; David J Liewehr; Maria J Merino; STEVEN ROSENBERG
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3127-32.
2003: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Suzanne Topalian; Richard M Sherry; Nicholas P Restifo; John R Wunderlich; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Linda Gritz; Dennis Panicali; Donald E White
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2973-80.
2003: Giao Q Phan; Christopher E Touloukian; James C Yang; Nicholas P Restifo; Richard M Sherry; Patrick Hwu; Suzanne Topalian; Douglas J Schwartzentruber; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(4):349-56.
2003: Theresa G Zogakis; Fathia Gibril; Steven Libutti; Jeffrey A Norton; Donald E White; Robert T Jensen; H Richard Alexander
Management and outcome of patients with sporadic gastrinoma arising in the duodenum.
Annals of surgery 2003;238(1):42-8.
2003: Maria Bettinotti; Monica C Panelli; Erin Ruppe; Simone Mocellin; Giao Q Phan; Donald E White; Francesco M Marincola
Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178.
International journal of cancer. Journal international du cancer 2003;105(2):210-6.
2003: STEVEN ROSENBERG; James C Yang; Richard M Sherry; Patrick Hwu; Suzanne Topalian; Douglas J Schwartzentruber; Nicholas P Restifo; Leah R Haworth; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.
Human gene therapy 2003;14(8):709-14.
2002: Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne Topalian; Richard M Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul H Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Science (New York, N.Y.) 2002;298(5594):850-4.
2002: Mark E Dudley; John R Wunderlich; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne Topalian; Richard M Sherry; Francesco M Marincola; Susan F Leitman; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Azam Nahvi; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(3):243-51.
2002: Lisa M Guirguis; James C Yang; Donald E White; Seth M Steinberg; David J Liewehr; STEVEN ROSENBERG; Douglas J Schwartzentruber
Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastases.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(1):82-7.
2001: Giao Q Phan; Peter Attia; Seth M Steinberg; Donald E White; STEVEN ROSENBERG
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3477-82.
2000: C E Marroquin; Donald E White; Seth M Steinberg; STEVEN ROSENBERG; Douglas J Schwartzentruber
Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(3):387-92.
1999: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Mario Sznol; Susan L Schwarz; Paul J Spiess; John R Wunderlich; Claudia A Seipp; JH Einhorn; Linda Rogers-Freezer; Donald E White
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(3):1690-5.
1999: R Hurst; Donald E White; J Heiss; David Lee; STEVEN ROSENBERG; Douglas J Schwartzentruber
Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(4):356-62.
1999: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Claudia A Seipp; JH Einhorn; Donald E White; Seth M Steinberg
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):968-75.
1998: STEVEN ROSENBERG; Y Zhai; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Claudia A Seipp; JH Einhorn; B Roberts; Donald E White
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.
Journal of the National Cancer Institute 1998;90(24):1894-900.
1998: STEVEN ROSENBERG; J C Yang; Donald E White; S M Steinberg
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response.
Annals of surgery 1998;228(3):307-19.
1998: Udai S Kammula; Donald E White; STEVEN ROSENBERG
Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer.
Cancer 1998;83(4):797-805.
1998: David Lee; Donald E White; R Hurst; STEVEN ROSENBERG; James C Yang
Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
The cancer journal from Scientific American 1998;4(2):86-93.
1998: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Mark E Dudley; Susan L Schwarz; Paul J Spiess; John R Wunderlich; Maria R Parkhurst; Y Kawakami; Claudia A Seipp; JH Einhorn; Donald E White
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Nature medicine 1998;4(3):321-7.
1996: Richard E Royal; Seth M Steinberg; R S Krouse; G Heywood; Donald E White; Patrick Hwu; Francesco M Marincola; D R Parkinson; Douglas J Schwartzentruber; Suzanne Topalian; J C Yang; STEVEN ROSENBERG
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.
The cancer journal from Scientific American 1996;2(2):91-8.
1996: STEVEN ROSENBERG; Donald E White
Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(1):81-4.
1996: C J Kim; Jeffery Taubenberger; TB Simonis; Donald E White; STEVEN ROSENBERG; Francesco M Marincola
Combination therapy with interferon-gamma and interleukin-2 for the treatment of metastatic melanoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(1):50-8.
1995: R S Krouse; Richard E Royal; G Heywood; Bruce D Weintraub; Donald E White; Seth M Steinberg; STEVEN ROSENBERG; Douglas J Schwartzentruber
Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(4):272-8.
1995: Francesco M Marincola; Peter Shamamian; Licia Rivoltini; Michael L Salgaller; JN Cormier; Nicholas P Restifo; TB Simonis; David Venzon; Donald E White; D R Parkinson
HLA associations in the antitumor response against malignant melanoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(4):242-52.
1995: J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; D R Parkinson; Francesco M Marincola; J S Weber; Claudia A Seipp; Donald E White; STEVEN ROSENBERG
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL-2.
Cancer 1995;76(4):687-94.
1995: Francesco M Marincola; Donald E White; A P Wise; STEVEN ROSENBERG
Combination therapy with interferon alfa-2a and interleukin-2 for the treatment of metastatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1110-22.
1995: M P MacFarlane; J C Yang; A S Guleria; R L White; Claudia A Seipp; JH Einhorn; Donald E White; STEVEN ROSENBERG
The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma.
Cancer 1995;75(4):1030-7.
1994: R L White; Douglas J Schwartzentruber; A Guleria; M P MacFarlane; Donald E White; E Tucker; STEVEN ROSENBERG
Cardiopulmonary toxicity of treatment with high dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma.
Cancer 1994;74(12):3212-22.
1994: A S Guleria; J C Yang; Suzanne Topalian; J S Weber; D R Parkinson; M P MacFarlane; R L White; Seth M Steinberg; Donald E White; JH Einhorn
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2714-22.
1994: STEVEN ROSENBERG; J R Yannelli; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; J S Weber; D R Parkinson; Claudia A Seipp; JH Einhorn; Donald E White
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
Journal of the National Cancer Institute 1994;86(15):1159-66.
1994: J C Yang; Suzanne Topalian; D Parkinson; Douglas J Schwartzentruber; J S Weber; S E Ettinghausen; Donald E White; Seth M Steinberg; David J Cole; H I Kim
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1572-6.
1994: Douglas J Schwartzentruber; S S Hom; R Dadmarz; Donald E White; J R Yannelli; Seth M Steinberg; STEVEN ROSENBERG; Suzanne Topalian
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1475-83.
1994: STEVEN ROSENBERG; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; J S Weber; D R Parkinson; Claudia A Seipp; JH Einhorn; Donald E White
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.
JAMA : the journal of the American Medical Association 1994;271(12):907-13.
1994: B A Pockaj; J C Yang; M T Lotze; Julie R Lange; W F Spencer; Seth M Steinberg; Suzanne Topalian; Douglas J Schwartzentruber; Donald E White; STEVEN ROSENBERG
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(1):22-8.
1993: B A Pockaj; Suzanne Topalian; Seth M Steinberg; Donald E White; STEVEN ROSENBERG
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):136-47.
1992: Julie R Lange; Seth M Steinberg; Gerard M Doherty; H N Langstein; Donald E White; Thomas Shawker; R C Eastman; Robert T Jensen; Jeffrey A Norton
A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.
Surgery 1992;112(6):1033-7; discussion 1037-8.
1992: Martin G Sanda; J C Yang; Suzanne Topalian; E S Groves; A Childs; Rubens Belfort; MD de Smet; Douglas J Schwartzentruber; Donald E White; M T Lotze
Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1643-9.
1992: J S Weber; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; Donald E White; STEVEN ROSENBERG
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):33-40.
1991: Douglas J Schwartzentruber; Donald E White; M H Zweig; Bruce D Weintraub; STEVEN ROSENBERG
Thyroid dysfunction associated with immunotherapy for patients with cancer.
Cancer 1991;68(11):2384-90.
1991: S F Stinson; T F DeLaney; J Greenberg; J C Yang; M H Lampert; J E Hicks; David Venzon; Donald E White; STEVEN ROSENBERG; E J Glatstein
Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma.
International journal of radiation oncology, biology, physics 1991;21(6):1493-9.
1989: STEVEN ROSENBERG; M T Lotze; J C Yang; W Marston Linehan; Claudia A Seipp; S Calabro; S E Karp; R M Sherry; S Steinberg; Donald E White
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1863-74.
1989: Bernard Fisher; A M Keenan; B S Garra; Seth M Steinberg; Donald E White; A M DiBisceglie; Jay H Hoofnagle; P Yolles; STEVEN ROSENBERG; M T Lotze
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1852-62.
1989: STEVEN ROSENBERG; M T Lotze; J C Yang; P M Aebersold; W Marston Linehan; Claudia A Seipp; Donald E White
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.
Annals of surgery 1989;210(4):474-84; discussion 484-5.
1989: Alfred E Chang; Seth M Steinberg; M Culnane; M H Lampert; A J Reggia; C G Simpson; J E Hicks; Donald E White; J J Yang; E Glatstein
Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1217-28.
1989: E E Lack; Seth M Steinberg; Donald E White; T Kinsella; E Glatstein; Alfred E Chang; STEVEN ROSENBERG
Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas.
Journal of surgical oncology 1989;41(4):263-73.
1989: Alfred E Chang; Seth M Steinberg; M Culnane; Donald E White
Determinants of survival in patients with unresectable colorectal liver metastases.
Journal of surgical oncology 1989;40(4):245-51.
1987: S E Ettinghausen; J G Moore; Donald E White; L Platanias; N S Young; STEVEN ROSENBERG
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.
Blood 1987;69(6):1654-60.
1986: D A Potter; T Kinsella; E Glatstein; R Wesley; Donald E White; Claudia A Seipp; Alfred E Chang; E E Lack; J Costa; STEVEN ROSENBERG
High-grade soft tissue sarcomas of the extremities.
Cancer 1986;58(1):190-205.
1985: STEVEN ROSENBERG; Claudia A Seipp; Donald E White; R Wesley
Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(5):698-709.
1985: D A Potter; J Glenn; T Kinsella; E Glatstein; E E Lack; C Restrepo; Donald E White; Claudia A Seipp; R Wesley; STEVEN ROSENBERG
Patterns of recurrence in patients with high-grade soft-tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(3):353-66.